Hemolytic anemia associated with dapsone PCP prophylaxis in GBM patients with normal G6PD activity
- PMID: 32047930
- PMCID: PMC7283030
- DOI: 10.1093/neuonc/noaa026
Hemolytic anemia associated with dapsone PCP prophylaxis in GBM patients with normal G6PD activity
Keywords: dapsone; glioblastoma; hemolytic anemia.
Figures
References
-
- Olteanu H, Harrington AM, George B, Hari PN, Bredeson C, Kroft SH. High prevalence of dapsone-induced oxidant hemolysis in North American SCT recipients without glucose-6-phosphate-dehydrogenase deficiency. Bone Marrow Transplant. 2012; 47(3):399–403. - PubMed
-
- Naik PM, Lyon GM 3rd, Ramirez A, et al. . Dapsone-induced hemolytic anemia in lung allograft recipients. J Heart Lung Transplant. 2008; 27(11):1198–1202. - PubMed
-
- Lewis JA, Petty WJ, Harmon M, et al. . Hemolytic anemia in two patients with glioblastoma multiforme: a possible interaction between vorinostat and dapsone. J Oncol Pharm Pract. 2015; 21(3):220–223. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources